The Balance between Plasmacytoid DC versus Conventional DC Determines Pulmonary Immunity to Virus Infections
Open Access
- 5 March 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (3) , e1720
- https://doi.org/10.1371/journal.pone.0001720
Abstract
Respiratory syncytial virus (RSV) infects nearly all infants by age 2 and is a leading cause of bronchiolitis. RSV may employ several mechanisms to induce immune dysregulation, including dendritic cell (DC) modulation during the immune response to RSV. Expansion of cDC and pDC by Flt3L treatment promoted an anti-viral response with reduced pathophysiology characterized by decreased airway hyperreactivity, reduced Th2 cytokines, increased Th1 cytokines, and a reduction in airway inflammation and mucus overexpression. These protective aspects of DC expansion could be completely reversed by depleting pDCs during the RSV infection. Expansion of DCs by Flt3L treatment enhanced in CD8+ T cell responses, which was reversed by depletion of pDC. These results indicate that a balance between cDC and pDC in the lung and its lymph nodes is crucial for the outcome of a pulmonary infection. Increased pDC numbers induced by Flt3L treatment have a protective impact on the nature of the overall immune environment.Keywords
This publication has 43 references indexed in Scilit:
- Organ-dependent in vivo priming of naive CD4+,but not CD8+,T cells by plasmacytoid dendritic cellsThe Journal of Experimental Medicine, 2007
- Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virusThe Journal of Experimental Medicine, 2006
- In vivooverexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cellsThe FASEB Journal, 2006
- Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLsThe Journal of Experimental Medicine, 2005
- Essential Role of Lung Plasmacytoid Dendritic Cells in Preventing Asthmatic Reactions to Harmless Inhaled AntigenThe Journal of Experimental Medicine, 2004
- Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venulesInternational Immunology, 2004
- Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunityThe Journal of Gene Medicine, 2003
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- Respiratory syncytial virus and other respiratory virusesThe Pediatric Infectious Disease Journal, 2003
- Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.The Journal of Experimental Medicine, 1996